Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Sodium hyaluronate eye drops are eye drops of the artificial tear type, mainly used to improve the symptoms of dryness and fatigue, and have obvious effects on dry eye diseases.
Global Sodium Hyaluronate for Ophthalmology market is projected to reach US$ 1232.6 million in 2029, increasing from US$ 658 million in 2022, with the CAGR of 9.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sodium Hyaluronate for Ophthalmology market research.
Key manufacturers engaged in the Sodium Hyaluronate for Ophthalmology industry include URSAPHARM Arzneimittel GmbH, Santen, Bayer Inc., Bausch & Lomb, Johnson & Johnson, United Laboratories, Alcon, Novax Pharma and Rohto, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Sodium Hyaluronate for Ophthalmology were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sodium Hyaluronate for Ophthalmology market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sodium Hyaluronate for Ophthalmology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Segment by Type
Segment by Application
Consumption by Region
The Sodium Hyaluronate for Ophthalmology report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Sodium Hyaluronate for Ophthalmology Market Overview
1.1 Product Overview and Scope of Sodium Hyaluronate for Ophthalmology
1.2 Sodium Hyaluronate for Ophthalmology Segment by Type
1.2.1 Global Sodium Hyaluronate for Ophthalmology Market Value Comparison by Type (2023-2029)
1.2.2 0.001
1.2.3 0.003
1.3 Sodium Hyaluronate for Ophthalmology Segment by Application
1.3.1 Global Sodium Hyaluronate for Ophthalmology Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Retail
1.3.4 Other
1.4 Global Sodium Hyaluronate for Ophthalmology Market Size Estimates and Forecasts
1.4.1 Global Sodium Hyaluronate for Ophthalmology Revenue 2018-2029
1.4.2 Global Sodium Hyaluronate for Ophthalmology Sales 2018-2029
1.4.3 Global Sodium Hyaluronate for Ophthalmology Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Sodium Hyaluronate for Ophthalmology Market Competition by Manufacturers
2.1 Global Sodium Hyaluronate for Ophthalmology Sales Market Share by Manufacturers (2018-2023)
2.2 Global Sodium Hyaluronate for Ophthalmology Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Sodium Hyaluronate for Ophthalmology Average Price by Manufacturers (2018-2023)
2.4 Global Sodium Hyaluronate for Ophthalmology Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Sodium Hyaluronate for Ophthalmology, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sodium Hyaluronate for Ophthalmology, Product Type & Application
2.7 Sodium Hyaluronate for Ophthalmology Market Competitive Situation and Trends
2.7.1 Sodium Hyaluronate for Ophthalmology Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sodium Hyaluronate for Ophthalmology Players Market Share by Revenue
2.7.3 Global Sodium Hyaluronate for Ophthalmology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sodium Hyaluronate for Ophthalmology Retrospective Market Scenario by Region
3.1 Global Sodium Hyaluronate for Ophthalmology Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Sodium Hyaluronate for Ophthalmology Global Sodium Hyaluronate for Ophthalmology Sales by Region: 2018-2029
3.2.1 Global Sodium Hyaluronate for Ophthalmology Sales by Region: 2018-2023
3.2.2 Global Sodium Hyaluronate for Ophthalmology Sales by Region: 2024-2029
3.3 Global Sodium Hyaluronate for Ophthalmology Global Sodium Hyaluronate for Ophthalmology Revenue by Region: 2018-2029
3.3.1 Global Sodium Hyaluronate for Ophthalmology Revenue by Region: 2018-2023
3.3.2 Global Sodium Hyaluronate for Ophthalmology Revenue by Region: 2024-2029
3.4 North America Sodium Hyaluronate for Ophthalmology Market Facts & Figures by Country
3.4.1 North America Sodium Hyaluronate for Ophthalmology Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Sodium Hyaluronate for Ophthalmology Sales by Country (2018-2029)
3.4.3 North America Sodium Hyaluronate for Ophthalmology Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sodium Hyaluronate for Ophthalmology Market Facts & Figures by Country
3.5.1 Europe Sodium Hyaluronate for Ophthalmology Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Sodium Hyaluronate for Ophthalmology Sales by Country (2018-2029)
3.5.3 Europe Sodium Hyaluronate for Ophthalmology Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sodium Hyaluronate for Ophthalmology Market Facts & Figures by Country
3.6.1 Asia Pacific Sodium Hyaluronate for Ophthalmology Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Sodium Hyaluronate for Ophthalmology Sales by Country (2018-2029)
3.6.3 Asia Pacific Sodium Hyaluronate for Ophthalmology Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sodium Hyaluronate for Ophthalmology Market Facts & Figures by Country
3.7.1 Latin America Sodium Hyaluronate for Ophthalmology Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Sodium Hyaluronate for Ophthalmology Sales by Country (2018-2029)
3.7.3 Latin America Sodium Hyaluronate for Ophthalmology Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Sodium Hyaluronate for Ophthalmology Market Facts & Figures by Country
3.8.1 Middle East and Africa Sodium Hyaluronate for Ophthalmology Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Sodium Hyaluronate for Ophthalmology Sales by Country (2018-2029)
3.8.3 Middle East and Africa Sodium Hyaluronate for Ophthalmology Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sodium Hyaluronate for Ophthalmology Sales by Type (2018-2029)
4.1.1 Global Sodium Hyaluronate for Ophthalmology Sales by Type (2018-2023)
4.1.2 Global Sodium Hyaluronate for Ophthalmology Sales by Type (2024-2029)
4.1.3 Global Sodium Hyaluronate for Ophthalmology Sales Market Share by Type (2018-2029)
4.2 Global Sodium Hyaluronate for Ophthalmology Revenue by Type (2018-2029)
4.2.1 Global Sodium Hyaluronate for Ophthalmology Revenue by Type (2018-2023)
4.2.2 Global Sodium Hyaluronate for Ophthalmology Revenue by Type (2024-2029)
4.2.3 Global Sodium Hyaluronate for Ophthalmology Revenue Market Share by Type (2018-2029)
4.3 Global Sodium Hyaluronate for Ophthalmology Price by Type (2018-2029)
5 Segment by Application
5.1 Global Sodium Hyaluronate for Ophthalmology Sales by Application (2018-2029)
5.1.1 Global Sodium Hyaluronate for Ophthalmology Sales by Application (2018-2023)
5.1.2 Global Sodium Hyaluronate for Ophthalmology Sales by Application (2024-2029)
5.1.3 Global Sodium Hyaluronate for Ophthalmology Sales Market Share by Application (2018-2029)
5.2 Global Sodium Hyaluronate for Ophthalmology Revenue by Application (2018-2029)
5.2.1 Global Sodium Hyaluronate for Ophthalmology Revenue by Application (2018-2023)
5.2.2 Global Sodium Hyaluronate for Ophthalmology Revenue by Application (2024-2029)
5.2.3 Global Sodium Hyaluronate for Ophthalmology Revenue Market Share by Application (2018-2029)
5.3 Global Sodium Hyaluronate for Ophthalmology Price by Application (2018-2029)
6 Key Companies Profiled
6.1 URSAPHARM Arzneimittel GmbH
6.1.1 URSAPHARM Arzneimittel GmbH Corporation Information
6.1.2 URSAPHARM Arzneimittel GmbH Description and Business Overview
6.1.3 URSAPHARM Arzneimittel GmbH Sodium Hyaluronate for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.1.4 URSAPHARM Arzneimittel GmbH Sodium Hyaluronate for Ophthalmology Product Portfolio
6.1.5 URSAPHARM Arzneimittel GmbH Recent Developments/Updates
6.2 Santen
6.2.1 Santen Corporation Information
6.2.2 Santen Description and Business Overview
6.2.3 Santen Sodium Hyaluronate for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Santen Sodium Hyaluronate for Ophthalmology Product Portfolio
6.2.5 Santen Recent Developments/Updates
6.3 Bayer Inc.
6.3.1 Bayer Inc. Corporation Information
6.3.2 Bayer Inc. Description and Business Overview
6.3.3 Bayer Inc. Sodium Hyaluronate for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bayer Inc. Sodium Hyaluronate for Ophthalmology Product Portfolio
6.3.5 Bayer Inc. Recent Developments/Updates
6.4 Bausch & Lomb
6.4.1 Bausch & Lomb Corporation Information
6.4.2 Bausch & Lomb Description and Business Overview
6.4.3 Bausch & Lomb Sodium Hyaluronate for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bausch & Lomb Sodium Hyaluronate for Ophthalmology Product Portfolio
6.4.5 Bausch & Lomb Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Sodium Hyaluronate for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Johnson & Johnson Sodium Hyaluronate for Ophthalmology Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 United Laboratories
6.6.1 United Laboratories Corporation Information
6.6.2 United Laboratories Description and Business Overview
6.6.3 United Laboratories Sodium Hyaluronate for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.6.4 United Laboratories Sodium Hyaluronate for Ophthalmology Product Portfolio
6.6.5 United Laboratories Recent Developments/Updates
6.7 Alcon
6.6.1 Alcon Corporation Information
6.6.2 Alcon Description and Business Overview
6.6.3 Alcon Sodium Hyaluronate for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Alcon Sodium Hyaluronate for Ophthalmology Product Portfolio
6.7.5 Alcon Recent Developments/Updates
6.8 Novax Pharma
6.8.1 Novax Pharma Corporation Information
6.8.2 Novax Pharma Description and Business Overview
6.8.3 Novax Pharma Sodium Hyaluronate for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Novax Pharma Sodium Hyaluronate for Ophthalmology Product Portfolio
6.8.5 Novax Pharma Recent Developments/Updates
6.9 Rohto
6.9.1 Rohto Corporation Information
6.9.2 Rohto Description and Business Overview
6.9.3 Rohto Sodium Hyaluronate for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Rohto Sodium Hyaluronate for Ophthalmology Product Portfolio
6.9.5 Rohto Recent Developments/Updates
6.10 Thea Pharmaceuticals
6.10.1 Thea Pharmaceuticals Corporation Information
6.10.2 Thea Pharmaceuticals Description and Business Overview
6.10.3 Thea Pharmaceuticals Sodium Hyaluronate for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Thea Pharmaceuticals Sodium Hyaluronate for Ophthalmology Product Portfolio
6.10.5 Thea Pharmaceuticals Recent Developments/Updates
6.11 Scope Ophthalmics Ltd
6.11.1 Scope Ophthalmics Ltd Corporation Information
6.11.2 Scope Ophthalmics Ltd Sodium Hyaluronate for Ophthalmology Description and Business Overview
6.11.3 Scope Ophthalmics Ltd Sodium Hyaluronate for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Scope Ophthalmics Ltd Sodium Hyaluronate for Ophthalmology Product Portfolio
6.11.5 Scope Ophthalmics Ltd Recent Developments/Updates
6.12 Prestige Consumer Healthcare
6.12.1 Prestige Consumer Healthcare Corporation Information
6.12.2 Prestige Consumer Healthcare Sodium Hyaluronate for Ophthalmology Description and Business Overview
6.12.3 Prestige Consumer Healthcare Sodium Hyaluronate for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Prestige Consumer Healthcare Sodium Hyaluronate for Ophthalmology Product Portfolio
6.12.5 Prestige Consumer Healthcare Recent Developments/Updates
6.13 Medicom Healthcare Ltd
6.13.1 Medicom Healthcare Ltd Corporation Information
6.13.2 Medicom Healthcare Ltd Sodium Hyaluronate for Ophthalmology Description and Business Overview
6.13.3 Medicom Healthcare Ltd Sodium Hyaluronate for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Medicom Healthcare Ltd Sodium Hyaluronate for Ophthalmology Product Portfolio
6.13.5 Medicom Healthcare Ltd Recent Developments/Updates
6.14 Altacor
6.14.1 Altacor Corporation Information
6.14.2 Altacor Sodium Hyaluronate for Ophthalmology Description and Business Overview
6.14.3 Altacor Sodium Hyaluronate for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Altacor Sodium Hyaluronate for Ophthalmology Product Portfolio
6.14.5 Altacor Recent Developments/Updates
6.15 Optrex
6.15.1 Optrex Corporation Information
6.15.2 Optrex Sodium Hyaluronate for Ophthalmology Description and Business Overview
6.15.3 Optrex Sodium Hyaluronate for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Optrex Sodium Hyaluronate for Ophthalmology Product Portfolio
6.15.5 Optrex Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sodium Hyaluronate for Ophthalmology Industry Chain Analysis
7.2 Sodium Hyaluronate for Ophthalmology Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sodium Hyaluronate for Ophthalmology Production Mode & Process
7.4 Sodium Hyaluronate for Ophthalmology Sales and Marketing
7.4.1 Sodium Hyaluronate for Ophthalmology Sales Channels
7.4.2 Sodium Hyaluronate for Ophthalmology Distributors
7.5 Sodium Hyaluronate for Ophthalmology Customers
8 Sodium Hyaluronate for Ophthalmology Market Dynamics
8.1 Sodium Hyaluronate for Ophthalmology Industry Trends
8.2 Sodium Hyaluronate for Ophthalmology Market Drivers
8.3 Sodium Hyaluronate for Ophthalmology Market Challenges
8.4 Sodium Hyaluronate for Ophthalmology Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research